Staphylococcal and streptococcal infections

Staphylococcal infections

  • More than 30 staphylococcal species exist
  • All are part of normal skin and mucous membrane flora
  • They are either coagulase-positive or negative
  • The most important coagulase-positive species is Staph. aureus

Staph aureus

  • 30% adults carry Staph. aureus in their anterior nares
  • Carriers transfer the organism to skin allowing a portal of entry
  • The organism has several putative determinant of pathogenicity including:
    • Cell wall constituents
    • Cell surface proteins
    • Toxins  (e.g. haemolysins and leukocidins)
    • Enzymes (e.g. coagulase, protease, hyaluronidase)
  • The organism is both aerobic and anaerobic on blood agar
  • Microscopically it is gram-positive
  • Forms clusters on solid media
  • There is increasing spread of clones resistant to beta-lactam antibiotics (e.g. MRSA)
  • Clinically it produces skin and soft tissue infections including
    • Impetigo
    • Folliculitis
    • Cellulitis
  • Deeper infections may occur after trauma or surgery
  • Metastatic infection may result in 
    • Endocarditis
    • Pericarditis
    • Osteomyelitis 
    • Lung abscesses
  • Treatment is with antistaphylococcal antibiotics (e.g. flucloxacillin)
  • In MRSA Vancomycin is the treatment of choice

Coagulase-negative staphylococci

  • Staph. epidermidis and Staph. saprophyticus are the commonest human pathogens
  • Staph. epidermidis is a common cause of nosocomial bacteraemia
  • Often associated with indwelling catheters and prosthetic materials
  • Is a common cause of prosthetic valve endocarditis
  • Its is often multiply antibiotic resistant
  • Treatment may require removal of line or prosthesis

Streptococcal infections

  • Streptococci are gram-positive cocci
  • More than 30 species have been identified
  • On solid media they grow in pairs or chains
  • They are catalase negative
  • Beta-haemolytic streptococci are classified according to their Lancefield group
  • The following are human pathogens
    • Strep. pyogenes (group A Streptococcus)
    • Group C and G streptococci
    • Strep. pneumoniae (pneumococcus)
    • Group B Streptococcus
    • viridans group streptococci
    • Enterococcus

Strep. pyogenes

  • Important human pathogen
  • Causes various cutaneous and systemic infections including
    • Streptococcal pharyngitis
    • Scarlet fever
    • Rheumatic fever
    • Post-streptococcal glomerulonephritis
  • The bacteria is sensitive to penicillin

Strep. pneumoniae

  • Common bacterial pathogen
  • Found in the nasopharynx of 20% of adults
  • On a Gram-stain it appears as a diplococcus
  • It is alpha-haemolytic on blood agar
  • Common cause of localised and systemic infections including
    • Otitis media
    • Sinusitis
    • Meningitis
    • Pneumonia
    • Endocarditis
    • Osteomyelitis
  • Infection can be prevented by the pneumococcal vaccine
  • Resistance to penicillin is increasing worldwide

Viridans group streptococci

  • The viridans group of streptococci are a diverse group of organisms
  • They are respiratory, gastrointestinal and oral cavity commensals
  • Infection usually occurs in immunocompromised hosts
  • Principal virulence trait is to adhere to cardiac valves and cause endocarditis
  • Account for 30 - 40% of cases of endocarditis
  • Most occur in patients with valvular heart disease
  • Other risk factors include:
    • Prosthetic heart valves
    • Intravenous drug abuse
  • Most are viridans streptococcal species are sensitive to penicillin

Enterococcus spp.

  • Enterococci are facultative anaerobes
  • They are common commensal of the gastrointestinal tract
  • They are significant cause of nosocomial infection including
    • Urinary tract infections
    • Endocarditis
    • Intra-abdominal infection
  • Risk factors for infection include
    • Severe underlying disease
    • Previous surgery
    • Previous antibiotic therapy
    • Renal failure
    • The presence of vascular or urinary catheters
  • Mortality from enterococcal infection is high
  • Intrinsically resistant to beta-lactams and aminoglycosides
  • They can also acquire resistance to Vancomycin
  • Management of Vancomycin-resistant enterococcus (VRE) is difficult

Bibliography

Herwaldt L A.  Staphylococcus aureus nasal carriage and surgical site infections.  Surgery 2003;  134 (Suppl 5):  S2-S9.

Lowy F D.  Staphylococcus aureus infections.  N Engl J Med 1998;  339:  520-552.

 

 
 

Copyright © 1997- 2012 Surgical-tutor.org.uk